BioMed Research International

Prognostic Assessment and Management of Liver Cirrhosis 2020


Publishing date
01 Jan 2021
Status
Published
Submission deadline
04 Sep 2020

Lead Editor

1General Hospital of Northern Theater Command, Shenyang, China

2ARNAS - Civico, Palermo, Italy

3Botucatu Medical School - Universidade Estadual Paulista (UNESP), São Paulo, Brazil


Prognostic Assessment and Management of Liver Cirrhosis 2020

Description

Liver cirrhosis is a major cause of death worldwide. According to the most recent report of the global, regional, and national burden of liver cirrhosis by cause in 195 countries and territories 1990–2017, liver cirrhosis related deaths constitute 2.4% of total deaths globally in 2017 as compared to 1.9% in 1990; the number of liver cirrhosis related deaths globally is also increased from less than 899000 deaths in 1990 to more than 1.32 million deaths in 2017.

Lots of novel therapies for liver cirrhosis and its complications have been greatly evolved during the past decades. However, liver transplantation remains the sole curative treatment option. Given the dismal prognosis of liver cirrhosis, it is very important for clinicians and patients to understand the potential risk factors for early death and therapeutic algorithms.

The aim of this Special Issue is to collate original research articles and review articles that explore the prognostic assessment and management of liver cirrhosis. We are particularly interested in high-quality systematic reviews and meta-analyses in this field.

Potential topics include but are not limited to the following:

  • Short- and long-term follow-up outcomes of liver cirrhosis
  • Novel biomarkers or mathematical models for assessing the short- and long-term survival of liver cirrhosis
  • Novel stages of liver cirrhosis
  • Role of nutritional status, portal haemodynamic status, cardiac function, and renal function for the prognostic assessment of liver cirrhosis
  • Impact of therapeutic options on the prognosis of liver cirrhosis, such as direct antiviral drugs, statins, anticoagulants, non-selective beta-blockers in ascites, early use of transjugular intrahepatic portosystemic shunt in high-risk variceal bleeding, endoscopic treatment of variceal bleeding, etc.
  • Impact of portal vein thrombosis on the prognosis of liver cirrhosis
  • Management of upper gastrointestinal bleeding, ascites, hepatic encephalopathy, hepatic hydrothorax, hypersplenism, hepatic myelopathy, and portal vein thrombosis in liver cirrhosis
  • Early use of TIPS in severe complications of liver cirrhosis
  • Subclassificaiton of acute kidney injury in liver cirrhosis
  • Early identification and management of acute kidney injury in liver cirrhosis

Articles

  • Special Issue
  • - Volume 2021
  • - Article ID 1093702
  • - Research Article

Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma

Zhe Yu | Xuemei Ma | ... | Yongping Yang
  • Special Issue
  • - Volume 2020
  • - Article ID 8835824
  • - Research Article

Oral Health-Related Quality of Life in Chronic Liver Failure Patients Measured by OHIP-14 and GOHAI

Maryam Zahed | Mohammad Ali Ranjbar | Azita Azad
  • Special Issue
  • - Volume 2020
  • - Article ID 5487659
  • - Research Article

Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study

Aein Azarang | Omid Farshad | ... | Ahmad Gholami
  • Special Issue
  • - Volume 2020
  • - Article ID 5162541
  • - Research Article

Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis

Zhanyi Li | Yu Liu | ... | Yutian Chong
  • Special Issue
  • - Volume 2020
  • - Article ID 1487593
  • - Research Article

Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis

Raphael Iglesias de Oliveira Vidal | Edison Iglesias de Oliveira Vidal | ... | Joaquim Ribeiro Filho
  • Special Issue
  • - Volume 2020
  • - Article ID 3801748
  • - Research Article

Four Autophagy-Related lncRNAs Predict the Prognosis of HCC through Coexpression and ceRNA Mechanism

Hao Wu | Tiantian Liu | ... | Qiang Zhu
  • Special Issue
  • - Volume 2020
  • - Article ID 9609731
  • - Review Article

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges

Hong Zhao | Qi Wang | ... | Wen Xie
  • Special Issue
  • - Volume 2020
  • - Article ID 7929610
  • - Research Article

Intestinal Clostridioides difficile Can Cause Liver Injury through the Occurrence of Inflammation and Damage to Hepatocytes

Soomin Lee | Heeyoung Lee | ... | Yohan Yoon
  • Special Issue
  • - Volume 2020
  • - Article ID 7372868
  • - Clinical Study

The Prognosis Analysis of Liver Cirrhosis with Acute Variceal Bleeding and Validation of Current Prognostic Models: A Large Scale Retrospective Cohort Study

Yan Zhao | Mudan Ren | ... | Shuixiang He
  • Special Issue
  • - Volume 2020
  • - Article ID 5062873
  • - Research Article

Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure

Xiaoping Wang | Mengying Sun | ... | Weizheng Zeng
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.